tiprankstipranks

Revance price target raised to $38 from $35 at Needham

Needham analyst Serge Belanger raised the firm’s price target on Revance to $38 from $35 and keeps a Buy rating on the shares. The company’s Q4 preliminary sales were "solid" as its management also provided an update on the Daxxify commercial launch, the analyst tells investors in a research note. Belanger adds that the $10.5M-$11.5M in preliminary Q4 Daxxify sales drove yesterday’s upside in the stock as little to no Daxxify sales were expected in the quarter.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on RVNC:

Disclaimer & DisclosureReport an Issue